NewsRx

Search our medical news database

Health Maintenance Organizations

Rep. Boustany Hauled in $1.25 Million From Health and Insurance Industry

Published in State and Local Health Law Weekly, September 24th, 2009

Public Campaign Action Fund raised serious conflict of interest questions about Rep. Charles Boustany (R-La.) and the expected opposing remarks he will deliver tonight in response to President Barack Obama's speech to a joint session of Congress on health care reform.

According to the nonpartisan Center for Responsive Politics, Rep. Boustany has received $1,256,056 from health and insurance interests since first being elected in 2004. The total counts for more than 20 percent of all of his fundraising.

"There is a conflict of interest when members of Congress stand before the public and recite the same talking points put forth by lobbyists and the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of State and Local Health Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook